Skip to main content

Middlesex Water Company to Present at Janney’s 5th Annual Virtual Water Utilities Conference

ISELIN, N.J., Sept. 12, 2025 (GLOBE NEWSWIRE) — Middlesex Water Company (NASDAQ: MSEX) has announced that its Chair, President and Chief Executive Officer, Nadine Leslie, and Senior Vice President, Chief Financial Officer and Treasurer, Mohammed G. (Rally) Zerhouni, are scheduled to participate in the 5th Annual Virtual Water Utilities Conference hosted by Janney Montgomery Scott on Wednesday, September 17, 2025 at 8:00am ET. Mrs. Leslie and Mr. Zerhouni will discuss the Company business strategy. The conference is a virtual event moderated by Michael Gaugler, Janney’s Senior Analyst and Managing Director, Utility & Infrastructure. The live webcast of the fireside chat will be available at https://wsw.com/webcast/jms14/msex/1695155 and will also be posted on Middlesex Water’s website www.middlesexwater.com under Investors...

Continue reading

Virbac : Public release of the Half-Year Financial Report at 30 June 2025.

The Group released and filed its 2025 half-year financial report with the French “Autorité des marchés financiers”. The document is also available on the corporate website, at corporate.virbac.com, under “Investors”, “Financial Reports”.AttachmentPublic release of the Half-Year Financial Report_06.25

Continue reading

Oncotelic Therapeutics Highlights 2 Years of Clinical and Regulatory Advancements Across Late-Stage Pipeline

AGOURA HILLS, Calif., Sept. 12, 2025 (GLOBE NEWSWIRE) — via IBN — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“OTLC” or the “Company”),  a clinical-stage biopharmaceutical company developing transformative oncology and immunotherapy treatments, today announces a summary of its major accomplishments over the past two years. These milestones underscore meaningful clinical progress and regulatory validation across the Company’s lead drug candidates. Oncotelic’s pipeline includes multiple late-stage programs targeting oncology and rare diseases, with several drug candidates achieving significant clinical milestones Two-Year Clinical Progress SnapshotOT-101 (TGF-β inhibitor): Phase 3 for pancreatic cancer, with additional applications in ARDS/COVID-19 OXi4503 (vascular disrupting agent): Phase 2 in...

Continue reading

Evolution of Société BIC’s Board of Directors composition

   Evolution of Société BIC’s Board of Directors composition Clichy, France – September 12, 2025 – During its meeting held today, and upon recommendation of the Nominations, Governance and CSR Committee, the Board of Directors has coopted three new Directors, which cooptation will be submitted for ratification at the next Shareholders’ Meeting of May 2026:Rob Versloot, Société BIC’s new CEO as of September 15, 2025, replaces Gonzalve Bich as Director. As announced in December 2024, Gonzalve Bich will continue to serve as Senior Advisor to the Group. Albert Baladi, an experienced and highly respected leader in the consumer goods industry, replaces Jake Schwartz, who has decided to step down from his role as Independent Director. Albert Baladi will be a member of the Audit Committee and of the Nominations, Governance and CSR Committee. Geoffroy...

Continue reading

Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review

Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review PARIS, France, September 12, 2025, 5:45 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the inflammatory response in patients with chronic inflammatory diseases, announces today that following the annual review of the Euronext Paris indices on September 11, 2025, the Scientific Council of the Indices has decided to admit Abivax to the CAC Mid 60 and SBF 120 indices. This decision will take effect on Friday, September 19, 2025, after market close. The CAC Mid 60 and SBF 120 are key indices on the Euronext Paris exchange, representing mid-sized listed companies...

Continue reading

Virbac: 2025 Half-year results

Solid revenue growth in the first half of 2025 of +5.6% at constant exchange rates and scopeAdjusted recurring operating income² of 18.3% as a ratio to revenue, in line with our expectationsDown compared to 2024 due to phasing and non-recurring effects2025 targets confirmedRevenue growth expected between 4% and 6% at constant rates and scope Adjusted recurring operating income¹ expected around 16%CONSOLIDATED FIGURES AS OF JUNE 30in € million HY25 HY24 Variance 2025/2024       Revenues 738.3 702.9 5.0%Change at constant exchange rates1     7.8%Change at constant exchange rates and scope1     5.6%       Current operating profit, before amortization of assets arising from acquisitions2 135.0 150.4 -10.2%as a % of revenue 18.3% 21.4%  as a % of...

Continue reading

Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak

MONTREAL, Sept. 12, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, is pleased to announce that its shareholders have approved the previously announced plan of arrangement (the “Arrangement”) under Chapter XVI – Division II of the Business Corporations Act (Québec) involving CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”). At the special meeting of shareholders of Theratechnologies held earlier today, the arrangement resolution was approved by 97.44% of the votes cast by the holders of shares present in person or virtually or represented by proxy at the meeting, and by 97.43% of the votes cast by the holders of shares present in person or virtually or represented by proxy at the meeting,...

Continue reading

LiveOne (Nasdaq: LVO) Surpasses $5M in Bitcoin Holdings

Targets $500M Treasury Yield Strategy Expands Web3 strategy, tokenizing and monetizing 10,000+ hours of video content on blockchain Acquires additional 347,000 shares of PodcastOne (Nasdaq: PODC) common stock this quarter, for a total of ~2.1 million shares since PODC became a public companyLOS ANGELES, Sept. 12, 2025 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO), an award-winning, creator-first music, entertainment, and technology platform, announced today that it has increased its Bitcoin holdings to over $5 million. In addition, the company acquired an additional 347,000 shares of PodcastOne, bringing its total holdings to approximately 2.1 million shares since PODC became a public company. “Bitcoin represents a key component of our treasury strategy, providing both diversification and potential long-term growth,” said Robert...

Continue reading

Gray Media’s Local News Live to Launch New Weekly Show, The Good Side

ATLANTA, Sept. 12, 2025 (GLOBE NEWSWIRE) — Local News Live, Gray Media’s 24-hour national digital news network, is set to premiere a new uplifting weekly program, The Good Side, on September 13th. The Good Side will air every weekend on Gray stations nationwide and on Local News Live at 12pm ET Saturdays and Sundays. The Good Side Show will be hosted by Edward R. Murrow and Emmy award-winning journalist Debra Alfarone, who is a National Correspondent for Gray and Lead Anchor for Local News Live. Debra originated The Good Side as a bi-monthly feature to highlight individuals and initiatives making a positive difference.   The expansion to a weekly program is the result of overwhelmingly positive feedback to those stories. The half-hour show will include inspirational content produced by Debra and Gray journalists across the country. “We...

Continue reading

Wrap’s BolaWrap® 150 Adopted by City of Pavia, Italy Police as a Safer Alternative to Taser

Pavia Councilor cites that it’s “much less dangerous than the Taser¹” in press conference announcing decision MIAMI, Sept. 12, 2025 (GLOBE NEWSWIRE) —  Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a global leader in innovative public safety solutions, today announced that the City of Pavia, Italy, adopted the BolaWrap® hands-on device for its local police force, citing concerns over the safety record of Taser.The city has initially purchased four BolaWrap devices, with twelve officers currently undergoing training to ensure proper deployment. The decision follows a growing trend away from Tasers in Italy, as numerous agencies investigate the circumstances surrounding recent deaths2. We believe Pavia’s announcement represents a meaningful advancement in Italy’s commitment to avoiding loss of life and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.